Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod

Medical Microbiology and Immunology

Volumn 192, Issue 3, 2003, Pages 161-164

  Wenzel, K ^a   Saka, B ^a   Zimmermann, R ^a   Gundlach, K K H ^a   Barten, M ^a   Gross, G ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Florid oral papillomatosis; Imiquimod; Papillomatosis of the lip; Squamous cell carcinoma; Topical immunotherapy

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; BENIGN TUMOR; BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG DOSE REGIMEN; ELECTROSURGERY; EROSION; EXCISION; FEMALE; HISTOLOGY; HUMAN; HYPERKERATOSIS; IMMUNOTHERAPY; IRRITATION; LASER SURGERY; LIP RECONSTRUCTION; LOWER LIP; LYMPH NODE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOUTH MUCOSA; MOUTH TUMOR; NECK DISSECTION; PAIN; PAPILLOMATOSIS; PLASTIC SURGERY; PRIORITY JOURNAL; RECURRENT DISEASE; SCALPEL; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; UPPER LIP; VERRUCA VULGARIS;

AMINOQUINOLINES; CARCINOMA, SQUAMOUS CELL; ELECTROSURGERY; FEMALE; HUMANS; LASER SURGERY; LIP NEOPLASMS; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMA;

EID: 0042831196     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-002-0172-8     Document Type: Article

References (35)

1. Arany I, Tyring SK, Stanley MA, et al (1999) Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Antiviral Res 43:55-63
2. Arrese J, Paquet P, Claessens N, et al (2001) Dermal dentritic cells in anogenital warty lesions unresponsive to an immune-response modifier. J Cutan Pathol 28:131-134
3. Batsakis JG, Suarez P, el-Naggar AK (1999) Proliferative verrucous leukoplakia and its related lesions. Oral Oncol 35:354-359
4. Beutner KR, Geisse JR, Helman D, et al (1999) Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 41:1002-1007
5. Burg G, Sobetzko R (1990) Florid oral papillomatosis: an indication for etretinate. Hautarzt 41:314-316
6. Burns RP Jr, Ferbel B, Thomai M, et al (2000) The imidazoquinolinamines, imiquimod and R-848 induce functional but not phenotypic maturation of human epidermal Langerhans'cells. Clin Immunol 94:13-23
7. Cannon CR, Hayne ST (1993) Concurrent verrucous carcinomas of the lip and buccal mucosa. South Med J 86:691-693
8. Davis G, Wentworth J, Richard J. (2000) Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases. J Reprod Med 45:619-623
9. Diaz-Arrastia C (2001) Clinical and molecular responses on high-grade intraepithelial neoplasia treated with topical imiquimod 5%. Clin Cancer Res 10:3031-3033
10. Edwards L, Ferenczy A, Eron I, et al (1998) Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 134:25-30
11. Greer RO, Eversole LR, Crosby LK (1990) Detection of human papillomavirus-genomic DNA in oral epithelial dysplasias, oral smokeless tobacco-associated leukoplakias and epithelial malignancies. J Oral Maxillofac Surg 48:1201-1205
12. Gross G (2001) Condylomata acuminata und andere HPV-assoziierte Krankheitsbilder des Genitale und der Harnröhre. Leitlinien der Deutschen STD-Gesellschaft (DSTDG). Hautarzt 52:405-410
13. Hagedorn M, Weigel K, Kiefer G, et al (1978) Florid oral papillomatosis. A contribution to cytostatic therapy. Hautarzt 29:425-429
14. Hengge UR, Esser S, Schultewolter T, et al (2000) Self administered topical imiquimod for the treatment of common warts and mollusca contagiosa. Br J Dermatol 143:1028-1031
15. Liota E, Smith KJ, Buckley R, et al (2000) Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 4:76-82
16. Mackenzie-Wood A, Kossard S, Launey J de, et al (2001) Imiquimod 5% in the treatment of Bowen's disease. J Am Acad Dermatol 44:462-470
17. Marks R, Gebauer K, Shumack S, et al (2001) Imiquimod 5% cream in treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 44:807-813
18. Miller CS, Johnstone BM (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a metaanalysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endot 91:622-635
19. Miller RL, Gerster JF, Owens ML, et al (1999) Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunepharmacol 21:1-14
20. Ostwald CH, Müller P, Barten M, et al (1994) Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med 23:220-225
21. Pehoushek J, Smith KJ (2001) Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man. Arch Dermatol 137:14-16
22. Petzoldt D, Gross G (2001) Diagnostik und Therapie sexuell übertragbarer Krankheiten. Leitlinien 2001 der Deutschen STD-Gesellschaft. Springer, Heidelberg Berlin New York
23. Rinne D, Linhart C, Schöfer H (2000) Lip papillomatosis in immunodeficiency. Therapy with imiquimod. Br J Dermatol 142:196-197
24. Rock JA, Fisher ER (1960) Florid papillomatosis of the oral cavity and larynx. Arch Otolaryngol 72:593-598
25. Samitz MH, Weinberg RA (1963) Oral florid papillomatosis. Arch Dermatol 87:478-480
26. Shear M, Pindborg JJ (1980) Verrucous hyperplasia of the oral mucosa. Cancer 46:1855-1862
27. Slade HB (1998) Cytokine induction and modifying the immune response to human papilloma virus with imiquimod. Eur J Dermatol (Suppl 7):13-26
28. Slotweg PJ, Muller H (1983) Verrucous hyperplasia or verrucous carcinoma. An analysis of 27 patients. J Maxillofac Surg 11:13-19
29. Stockfleth E, Meyer T, Benninghoff B, Christophers E (2001) Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 144:1050-1053
30. Suzuki H, Wang B, Shirji GM, et al (2000) Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol 114:135-141
31. Syrjänen S (2003) HPV infections and oral tumors. Med Microbiol Immunol (in press)
32. Von Krogh G, Lacey CIN, Gross G, et al (2000) European Course on HPV-Associated Pathology (ECHPV): Guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 76:162-168
33. Wechsler HL, Fisher ER (1962) Oral florid papillomatosis. Arch Dermatol 86:480-492
34. Wigbels B, Luger T, Metze D (2001) Imiquimod - eine neue Therapiemöglichkeit der bowenoiden Papulose? Hautarzt 52:128-131
35. Winnen P (1983) Intrafocal bleomycin injection in florid oral papillomatosis (papillomatosis mucosae carcinoides). Z Hautkr 58:733-741